Streetbeat News

Corporate Responsibility

NSC

Norfolk Southern Corp. has labeled the near-term targets set by Ancora Alternatives LLC as 'highly unrealistic' and is urging its shareholders to vote for the company's nominees instead of those proposed by Ancora. This dispute highlights a significant disagreement between the railroad company and the investment firm regarding the strategic direction and management goals.

Portfolio Pulse from Benzinga Newsdesk

April 19, 2024 | 12:06 pm

NURO

NeuroMetrix has appointed Joshua S. Horowitz as a new independent director and has terminated its at-the-market equity facility. These strategic moves could signal a shift in the company's governance and financial strategy, potentially impacting investor sentiment and the company's future direction.

Portfolio Pulse from Benzinga Newsdesk

April 19, 2024 | 12:01 pm

AAPL

BA

NFLX

TSLA

Cathie Wood's Ark Invest buys $13M in Tesla stock and loads up on Bitcoin and Ethereum ETFs, amid discussions on Bitcoin halving and its impact. Wall Street faces potential 6th day of losses, influenced by Netflix and geopolitical tensions. Apple complies with China's security demands by removing Meta products from its App Store. Tesla recalls over 3,800 Cybertrucks due to unintended acceleration risk. Netflix faces growth challenges, and Boeing deals with safety concerns and whistleblower complaints.

Portfolio Pulse from Akanksha Bakshi

April 19, 2024 | 11:53 am

REAX

The Real Brokerage Inc. (REAX) has expanded its presence in Chicago and the surrounding states by adding Qamar Group to its team. Qamar Group, led by CEO Rafay Qamar and COO Jana Pierce, brings 36 agents and a track record of selling over 1,500 homes valued at $500 million since 2019. The group is recognized among the top 1% of teams in Illinois and has received numerous awards, including the Carly Award from the Chicago Association of Realtors for three consecutive years. This partnership aligns with Real's mission to support agents in growing their businesses and enhancing client service.

Portfolio Pulse from Benzinga Newsdesk

April 19, 2024 | 11:37 am

BSY

SBGSY

Bentley Systems has chosen not to comment on market speculation regarding potential strategic transaction discussions with Schneider Electric, who confirmed their ongoing talks as part of their One Software strategy.

Portfolio Pulse from Benzinga Newsdesk

April 19, 2024 | 11:35 am

DCFC

Tritium DCFC announced that on April 18, it and three of its Australian subsidiaries were deemed insolvent or likely to become insolvent. Consequently, an administrator was appointed, suspending the powers of the directors and transferring control of the company's affairs to the administrator.

Portfolio Pulse from Benzinga Newsdesk

April 19, 2024 | 11:31 am

AAPL

GOOGL

IXP

MSFT

VOX

Google's CEO Sundar Pichai announced a major restructuring to accelerate AI development, aiming to outpace competitors like Microsoft. The reorganization consolidates all AI teams under DeepMind, focusing on unified AI efforts and introducing a new Platform and Devices team. This move, the largest change at Alphabet since last year's AI unit integration, seeks to enhance product innovation and decision-making. Analysts view Alphabet's AI and cloud investments as key growth drivers, potentially boosting its shares alongside a speculated collaboration with Apple.

Portfolio Pulse from Anusuya Lahiri

April 19, 2024 | 11:07 am

PRQR

ProQR Therapeutics successfully defended a key patent for its Axiomer RNA editing platform against an opposition filed with the European Patent Office. The patent, part of ProQR's intellectual property for Axiomer, relates to editing oligonucleotides with chemical modifications to increase stability and recruit ADAR for editing target adenosine. The EPO's decision maintains ProQR's strong IP position on its proprietary ADAR mediated RNA editing technology.

Portfolio Pulse from Benzinga Newsdesk

April 19, 2024 | 11:06 am

DB

Deutsche Bank has reportedly made significant job cuts in its Asia private banking sector as part of an overhaul. This move is part of a broader strategy to restructure its operations in the region.

Portfolio Pulse from Charles Gross

April 19, 2024 | 10:47 am

ALVO

TEVA

Alvotech has signed a long-term agreement with a strategic partner to enhance access to Adalimumab-ryvk in the US market, supporting its financial guidance. The partnership with Teva Pharmaceuticals for commercializing Adalimumab-ryvk under the SIMLANDI brand in the US remains unchanged.

Portfolio Pulse from Benzinga Newsdesk

April 19, 2024 | 10:11 am